Sign Up to like & get
recommendations!
2
Published in 2023 at "Cancer Research"
DOI: 10.1158/1538-7445.am2023-914
Abstract: Background: Transgenic TCR-T cells targeting MART-1 and NY-ESO-1 for the treatment of melanoma and sarcoma, respectively, are associated with robust initial clinical responses. However, these responses are often not durable, and a significant proportion of…
read more here.
Keywords:
cell;
serum cytokine;
tcr;
preinfusion ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2018 at "Blood"
DOI: 10.1182/blood-2018-01-828343
Abstract: After treatment with chimeric antigen receptor (CAR) T cells, interleukin-15 (IL-15) elevation and CAR T-cell expansion are associated with non-Hodgkin lymphoma (NHL) outcomes. However, the association of preinfusion CAR product T-cell functionality with clinical outcomes…
read more here.
Keywords:
clinical outcomes;
product;
preinfusion;
cell ... See more keywords